Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Novo Nordisk A/S ADR buy TD Cowen

Start price
€93.00
04.12.23 / 50%
Target price
€106.28
04.12.24
Performance (%)
11.83%
End price
€104.00
05.12.24
Summary
This prediction ended on 05.12.24 with a price of €104.00. The prediction had a final performance of 11.83%. TD_Cowen has a follow-up prediction for Novo Nordisk A/S ADR where he still thinks Novo Nordisk A/S ADR is a Buy. Dividends of €1.08 are taken into consideration when calculating the performance. TD_Cowen has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Novo Nordisk A/S ADR 8.482% 8.482% -60.648%
iShares Core DAX® -0.099% 1.027% 31.262%
iShares Nasdaq 100 -1.085% 2.134% 14.536%
iShares Nikkei 225® -0.835% 8.556% 5.546%
iShares S&P 500 0.099% 2.881% 11.163%

Comments by TD_Cowen for this prediction

In the thread Novo Nordisk A/S ADR diskutieren
Prediction Buy
Perf. (%) 11.83%
Target price 106.283
Change
Ends at 04.12.24

Novo Nordisk A/S (NYSE: NVO) had its price target raised by analysts at TD Cowen from $105.00 to $115.00. They now have an "outperform" rating on the stock.
Ratings data for NVO provided by MarketBeat

In the thread Trading Novo Nordisk A/S ADR
Prediction Buy
Perf. (%) 11.83%
Target price 106.283
Change
Ends at 04.12.24

Die von TD_Cowen gewählte maximale Laufzeit wurde überschritten

Current prediction by TD_Cowen for Novo Nordisk A/S ADR

buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€47.20
19.08.25
€60.08
19.08.26
2.97%
22.08.25